The increasing phenomenon of vaping 5MeO dimethyltryptamine in this country presents considerable hazards and complex legal problems. Currently, 5MeO dimethyltryptamine remains a Schedule One substance under Canadian Controlled Drugs and Substances Act, rendering its possession and distribution p